PTH News and Press, Invesco DWA Healthcare Momentum ETF From 01/21/21

2020 was a busy year for global healthcare with unprecedented efforts to develop vaccines, treatments, and diagnostics for COVID-19. Deal flow in the sector continued to gain momentum in 2020, with M&A transactions and product licensing deals totalling five-year highs as large-cap...

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. PTH: a growth ETF in healthcare. For further details see: Healthcare Review Starting In 2021 And Focus On PTH

The COVID-19 pandemic has brought the healthcare sector in focus like never before. With an imminent second wave and Biden’s goal to broaden health care coverage, various forms of healthcare services should see huge demand. The Health Care Select Sector SPDR Fund (XLV), iShares U.S. He...

By Nick Kalivas, Senior Equity Product Strategist Health care presents the opportunity to invest in companies that are constantly innovating to improve quality of life and raise productivity. When thinking about growth, many investors default to technology, noting companies like Am...

Average analyst S&P 500 forecasts and S&P history Factoids: 2020 operating earnings: -21.1% and revenue: -3.7% 2021 operating earnings: +28.0% and revenue: +8.4% Net effect (2021 vs 2019): 2-year earnings about 1% higher and revenue about 4% higher. Standard & Poorȁ...

Background Information This presentation was done to derive portfolios through COVID-19 and the path towards recovery. Feel free to leave comments down below if there are any questions regarding our analyses and assumptions. Executive Summary Given the current situation with ...

In a market populated mostly with mediocre opportunities and led by a small number of high performers, we use extensive filtering to attempt to identify lesser-known or lesser-followed securities that also stand out from the crowd. Every week we review every ETF, every other security on the ...

Health insurance, hospitals and drug names all trade sharply lower following Bernie Sanders' convincing win in the Nevada caucuses ( XLV -2.4% ). More news on: Health Care Select Sect SPDR ETF, Molina Healthcare, Inc., Centene Corporation, Healthcare stocks news, Stocks on the move, To...

By Vinay Thapar and Frank Caruso US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. But investors can find good opportunities in the sector in companies with strong long-term business drivers that are relatively immune to ...

Aprea Therapeutics (NASDAQ: APRE ) opens for trading after raising the size of its IPO to 5.67M shares from 5M and pricing its IPO at $15 , the mid‐point of the $14‐$16 expected range. More news on: Aprea Therapeutics, Monopar Therapeutics, ADC Therapeutics SA, Healthcare st...